The proof is in the pudding: patient engagement in studying cannabidiol in mild cognitive impairment

The proof is in the pudding: patient engagement in studying cannabidiol in mild cognitive impairment

Abstract Background Patient engagement (PE) in clinical trials has gained importance yet remains uncommon, particularly in patients with mild cognitive impairment (MCI), a critical precursor to Alzheimer’s disease (AD). Cannabidiol (CBD) shows potential in slowing MCI progression due to its neuropro...

Descripció completa

Dades bibliogràfiques
Autors principals: Antonia Keck, Julia-Sophia Scheuermann, Petra Scheerbaum, Elmar Graessel, Kirsten R. Müller-Vahl
Format: Article
Idioma:English
Publicat: BMC 2025-01-01
Col·lecció:BMC Complementary Medicine and Therapies
Matèries:
Mild cognitive impairment
Alzheimer’s disease
Cannabidiol
Cannabis-based medicine
Patient engagement
Patient and public involvement
Accés en línia:https://doi.org/10.1186/s12906-025-04753-w

Internet

https://doi.org/10.1186/s12906-025-04753-w

Ítems similars